4 citations
,
March 2007 in “Annales de Dermatologie et de Vénéréologie” This review discusses the adverse effects of hair care products, highlighting irritation dermatitis and allergic contact eczema due to common allergens like paraphenylenediamine and glycerol monothioglycolate, but reports no clinical results.
October 2018 in “Emergency medicine news” This case report describes a 65-year-old man diagnosed with atraumatic splenic rupture, which is rare and can occur without trauma, following sudden-onset left-sided abdominal pain.
February 1991 in “Archives of Dermatology” The document lists dermatology job ads across the U.S. with good pay and benefits.
28 citations
,
January 2005 in “Photochemistry and Photobiology” This study found that overexpression of PKCepsilon in mouse epidermis was associated with increased susceptibility to metastatic squamous cell carcinoma, potentially through a mechanism involving tumor necrosis factor-alpha.
14 citations
,
January 2005 in “Cell Stress and Chaperones”
November 2021 in “Permskij medicinskij žurnal” This study found that women with menstrual dysfunction showed higher rates of magnesium, iron, and vitamin D deficiencies compared to women with normal menstrual function.
29 citations
,
January 2021 in “Translational Psychiatry” This study found that certain gene sets, including those involved in ligand-gated ion channel signaling and cell adhesion, are associated with Tourette syndrome, suggesting a potential neurobiological basis for the disorder.
1 citations
,
April 2020 in “medRxiv (Cold Spring Harbor Laboratory)” This study identified gene sets associated with Tourette Syndrome, implicating Ligand-gated Ion Channel Signaling, Lymphocytic, and Cell Adhesion and Trans-synaptic Signaling processes in the disorder's neurobiology.
January 2026 in “Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)” This study observed that baricitinib led to significant hair regrowth and improved psychological well-being in severe alopecia areata patients over 48 weeks, with 63.2% achieving a SALT score of ≤20.
127 citations
,
August 2016 in “The oncologist” This paper reviews adverse events related to hedgehog pathway inhibitors in advanced basal cell carcinoma patients, reporting no new clinical results but aiming to inform healthcare professionals for improved patient care.
44 citations
,
January 2013 in “International Journal of Trichology” This study found that 5 mg/day oral finasteride was effective and safe for improving hair outcomes in normoandrogenic postmenopausal women with androgenetic alopecia over 18 months.
36 citations
,
November 2016 in “European journal of dermatology/EJD. European journal of dermatology” This review examines systemic drugs that can cause changes in hair color and emphasizes the importance of reporting these adverse events, but it does not include new clinical outcomes.
34 citations
,
July 2011 in “Journal of the European Academy of Dermatology and Venereology” This study identified distinct dermoscopic patterns associated with different types of scalp tumors, highlighting variability in lesions related to patient age, gender, and tumor thickness.
11 citations
,
January 1999 in “Dermatology” 9 citations
,
September 2024 in “Journal of Clinical Medicine” This review examines the role of autoinflammation and immune dysregulation in hidradenitis suppurativa, linking it to genetic factors and autoinflammatory syndromes, but highlights the need for further research to fully understand its pathogenic mechanisms.
6 citations
,
September 2022 in “Vaccines” This study described cases of alopecia areata occurring after COVID-19 vaccination and highlights management using both topical and systemic therapies.
3 citations
,
August 2013 in “Journal of the National Cancer Institute” This study reported an almost doubling of advanced breast cancer incidence in women under 40 over three decades, but its significance remains uncertain and requires further confirmation.
2 citations
,
May 2024 in “Expert Opinion on Drug Safety” This study found that while infectious events may occur in alopecia areata patients treated with JAK inhibitors, these infections are usually manageable and rarely lead to permanent treatment discontinuation.
2 citations
,
August 2021 in “Revista Da Associacao Medica Brasileira” This review highlights existing research on the psychological effects of the COVID-19 pandemic, particularly noting increased depression and anxiety among women, but presents no new study results.
1 citations
,
March 2026 in “American Journal of Clinical Dermatology” In this Italian retrospective study, ritlecitinib 50 mg/day showed effectiveness and good tolerability for treating severe alopecia areata over 24 weeks, achieving significant hair regrowth particularly in adolescents, as well as improvements in eyebrows, eyelashes, nails, and quality of life, with mostly mild adverse effects.
1 citations
,
May 2024 in “Italian Journal of Dermatology and Venereology” This study supports the use of a national registry as an effective tool for documenting epidemiological data, disease progression, treatment responses, and quality of life impacts in patients with alopecia areata.
1 citations
,
July 2023 in “Cancers” In this multicentric retrospective study, researchers reported that cutaneous adverse events were common among advanced breast cancer patients treated with cyclin-dependent kinase inhibitors (CDK4/6i), generally mild, and manageable with topical treatments, though in some cases, they led to treatment discontinuation.
April 2026 in “Clinical and Experimental Dermatology” This study found that treating moderate-to-severe prurigo nodularis with dupilumab significantly improved itch severity, skin condition, and quality of life over 104 weeks, with a favorable safety profile, even in elderly and comorbid patients.
October 2025 in “Journal of the European Academy of Dermatology and Venereology” This study found that vitiligo elicited the most compassion and curiosity among general adults viewing AI-generated images of chronic skin diseases, while psoriasis was linked to higher perceptions of disgust and blame.
September 2025 in “Journal of the European Academy of Dermatology and Venereology” This real-world study found that baricitinib 4 mg daily was effective in promoting hair regrowth and improving psychological well-being in Italian adults with severe alopecia areata over 48 weeks, with 63.2% of patients achieving significant hair recovery and 9.4% experiencing adverse events.
March 2025 in “International Journal of Dermatology” This source does not report any results or findings, as no abstract is provided.
This research explores if COVID-19, analogous to SARS-CoV, may result in long-term pulmonary fibrosis in recovered patients, although current evidence on the persistence or resolution of lung changes over time remains unknown.
November 2024 in “International Journal of Dermatology” This study found that line-field confocal optical coherence tomography correlates well with histopathological and dermoscopic findings in alopecia areata, suggesting it could be a useful diagnostic and monitoring tool for the condition.
September 2024 in “Dermatology Reports” In this study, 45 patients with advanced basal cell carcinoma treated with the medication sonidegib experienced a 24% incidence of alopecia, with detailed trichoscopic and LC-OCT examination revealing specific hair changes, suggesting LC-OCT might help identify early signs of alopecia from sonidegib use.
August 2024 in “Frontiers in Public Health” In this study, researchers developed and tested an Italian version of the Skindex-16AA to assess Health-Related Quality of Life in patients with moderate-to-severe Alopecia Areata, emphasizing the importance of patient perception in evaluating their mental health and quality of life.